TherapeuticsMD, Inc. Other Current Liabilities
TherapeuticsMD, Inc. (TXMD) had Other Current Liabilities of $6.93 million as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2023-11-14
- 2023-09-30: Other Liabilities, Current $6.93M.
- 2023-06-30: Other Liabilities, Current $11.48M.
- 2023-03-31: Other Liabilities, Current $14.36M.
- 2022-12-31: Other Liabilities, Current $18.85M.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2023-09-30 | $6.93M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $11.48M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $14.36M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $18.85M 10-Q · filed 2023-11-14 | |
| 2022-09-30 | $43.57M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $59.23M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $41.23M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $13.34M 10-K · filed 2023-04-07 | $44.30M 10-Q · filed 2022-05-16 |
| 2020-12-31 | $38.17M 10-K · filed 2021-03-04 | |
| 2020-09-30 | $31.22M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $29.21M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $32.92M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $33.82M 10-K · filed 2021-03-04 | |
| 2019-09-30 | $43.20M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $22.38M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $19.61M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $18.33M 10-K · filed 2020-02-24 | |
| 2018-09-30 | $17.89M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $9.79M 10-Q · filed 2018-07-30 | |
| 2018-03-31 | $9.38M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $9.22M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $6.68M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $5.18M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $7.94M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $7.62M 10-K · filed 2018-02-23 | |
| 2016-09-30 | $8.24M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $6.30M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $6.17M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $7.54M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $6.39M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $5.89M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $4.88M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $3.84M 10-K · filed 2016-02-26 | |
| 2014-09-30 | $4.51M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $3.33M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $2.27M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $3.60M 10-K · filed 2015-03-12 | |
| 2013-09-30 | $2.07M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $1.33M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $1.14M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $833.65K 10-K · filed 2014-03-05 | $725.87K 10-K · filed 2013-03-12 |
| 2012-09-30 | $428.38K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $714.20K 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $412.89K 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $465.75K 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |